Frequently Asked Questions

No. The VOLO™ Score is not a diagnostic tool and does not replace clinical diagnosis of the patient's current health status, rather it provides the ability to see long-term health outlooks . This permits clinicians and their patients to implement informed lifestyle decisions early to improve long-term health. Early implementation of lifestyle choices are key to improving long-term health, before it is too late.

Genetic data is not yet fully integrated into the standard VOLO™ Score, but it is actively in development and represents the next significant evolution of the platform.

Biomarker strength indicates how strongly a biomarker is correlated to a particular health domain, based on Volo Health's models. These values range from 1 (weakest) to 10 (strongest), reflecting how strong the correlation is between the biomarker and the health domain score.

This allows physicians to see at a glance which biomarkers contribute most to each domain — and where to focus their attention first. The VOLO™ Score details will also provide personalized views for each patient, showing which biomarkers are negatively and positively influencing their VOLO Scores the most.

VOLO™ Scores do the heavy lifting before the patient walks in the door. Rather than spending the visit synthesizing raw lab values one by one, you can arrive with a clear visual snapshot of the patient's long-term health across multiple health domains, with the highest-priority health domains and biomarker relationships already identified. This shifts the conversation from data explanation to behavior modification — which is where clinicians tell us they desire to spend the most time with their patients.

VOLO™ Scores can be calculated with limited blood biomarkers due to our ability to impute missing biomarkers based on large population data, however the more biomarkers we can input for scoring, the better.

VOLO ™ Scores are generated based on a patient's bloodwork, vital signs, and biometric data. Because biomarkers change over time — in response to lifestyle choices, medication, and aging among others, — regular updates are essential to tracking progress and adjusting health and wellness recommendations on long-term health.

Every 3 to 6 months is the recommended cadence for most patients to actively track changes in their long-term health outlook provided through VOLO Scores. For highly motivated patients tracking specific lifestyle decisions, more frequent draws may be appropriate. Vital signs and physical measures should always be recorded on the same day as the blood draw for maximum accuracy

Individual lab values are typically evaluated against population reference ranges — flagging what is abnormal but offering little insight into how those values interact with other biomarker values, and what they mean for the patient's long-term health trajectory. The VOLO™ Score changes this by analyzing multiple biomarkers simultaneously across health domains, accounting for the patient's age and sex, and surfacing the combinations that are quietly driving long-term risk. A biomarker that appears perfectly normal in isolation can still contribute meaningfully to elevated long-term risk as determined by our algorithms' ability to interpret biomarker relationships. VOLO Scores make those patterns visible, giving the physician a level of insight that a standard lab review simply cannot provide

We are onboarding clinicians who would like to join the Clinician Pilot program. Contact our team and let them know you are interested in learning more about the program.

Measuring long-term health is achieved through VOLO™ Scores. Lab reference ranges provide insight into specific biomarker value, but this is incomplete and challenging to interpret, VOLO Scores provide you with composite health scores across key health domains, based on all biomarkers combined and their relationship to actual health outcomes. This provides a comprehensive view of your future health risk in 10-15 years.

The details of the VOLO Score also provide VOLO Modeled Ranges to compare to lab reference ranges. The VMR is derived from advanced data science using large and diverse population data to establishoptimal biomarker ranges for an individual that are based on actual health outcomes across the domains we score. This provides gender specific readings for a more precise understanding of how your long-term health is trending. This allows for early detection and lifestyle changes to drive significant changes in your future health.

VOLO™ Scores provide a snapshot of long-term health outlook. Over time, changes in VOLO™ Scores show whether lifestyle or care changes are improving an individual's future health trajectory.

No. VOLO™ Scores are designed to complement, not replace, professional medical advice. They help you understand your health and have more informed conversations with your care team.

Most health outcomes are driven by interactions across multiple biological systems and biomarkers. Single biomarkers and calculators that are focused on single biomarkers, likely do not sufficiently capture future health risks.

Add your health data in the VOLO™ Wellness App and your personalized scores are generated for you automatically.

VOLO™ Scores are built using advanced predictive models trained on real-world outcomes from millions of people, uncovering deeper health patterns that traditional methods may miss.

Yes—our models intelligently infer missing information using population-level intelligence, delivering insights even when input data is incomplete.

By identifying signals that indicate your long-term health may be trending in the wrong direction, VOLO™Scores provide information that can lead to healthy choices before health issues become symptoms or indicators of declining health. Discovering these long-term trends early is key to having the time to make life-changing results.

VOLO™ Scores provide the measurement of your long-term health outlook over time. Changes in VOLO Scores show whether lifestyle changes are improving an individual’s long-term health trajectory. Your health is the most important asset you own and measuring it should be clear and trackable.

No—VOLO™ Scores provide clarity and insights into long-term health to support better conversations and decisions between you and your health care practitioner. VOLO Scores focus on your long-term health, providing individuals and clinicians with a proactive rather than reactive system.

VOLO™ Scores are designed for individuals, clinicians, health and wellness companies, employers, and researchers seeking deeper long-term health insights.

Health data can be complex and requires deep analysis of the relationships and trends to better understand long term health. There are also many factors such as genetics, physical measurements, lifestyle choice, environment, and other factors that drive health outcomes. Physical measures are included in our models today, and other factors will be included over time so that we can better understand how factors outside of lab data may affect long term health.

VOLO™ Scores are personalized based on age, gender, biomarkers, and population-modeled health patterns—resulting in a comprehensive assessment of each individual’s long-term health

VOLO™ Age reflects how healthy your body systems are compared to the average health from diverse and large population datasets of people with the same sex and chronological age. A lower VOLO Age indicates better long-term health than the average person of the same sex and age

The VOLO™ Modeled Range (VMR) represents a sex and age specific biomarker range associated with good long-term health and wellness across the health domains we score, which afflict most people with chronic diseases experience in their lifetime. It is derived from the models that use major health domains and a 15-year timeframe. Laboratory reference ranges often focus on single biomarker-disease relationships. The VMR is derived from unbiased, data-driven analyses across the health domains. For example, traditional ranges might relate cholesterol only to heart disease, whereas our models assess broader, long-term impacts of cholesterol levels across many health domains. As a result, VMR ranges may differ from traditional lab reference ranges.

The VMR provides data-driven research-based perspectives and should be reviewed with your clinician.